Capone Mark Christopher

Director · MLAB, SERA

As of 2026-09-16, Capone Mark Christopher has 11 Form 4 transactions on record across 2 companies — 8 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $310KIndirect: $0$310Kas of 2026-09-16
  • Direct $310K
  • Indirect $0
MLABdirect2,423 sh$304K
SERAdirect3,037 sh$6K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

MLAB · 7 trades
2026-09-09: Award / grant, 2,423 sh ($0)2026-08-15: Option exercise, 2,784 sh ($0)2026-08-15: Option exercise, 2,784 sh ($0)2026-03-10: Purchase, 1,301 sh ($99K)2025-08-15: Option exercise, 1,404 sh ($0)2025-08-15: Option exercise, 1,404 sh ($0)2025-08-15: Award / grant, 2,784 sh ($0)
SERA · 4 trades
2026-07-10: Award / grant, 1,975 sh ($0)2026-07-10: Award / grant, 42,404 sh ($0)2026-07-10: Award / grant, 62,766 sh ($0)2026-07-10: Award / grant, 3,037 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-03-10MLABPurchase1,301 @ $76.35$99K+61.1% of holding3,429Form 4
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-09-09MLABAward / grant2,4232,423Form 4
2026-08-15MLABOption exercise2,7846,213Form 4
2026-08-15MLABOption exercise2,7840Form 4
2026-07-10SERAAward / grant1,97544,379Form 4
2026-07-10SERAAward / grant42,40442,404Form 4
2026-07-10SERAAward / grant62,76662,766Form 4
2026-07-10SERAAward / grant3,0373,037Form 4
2025-08-15MLABOption exercise1,4040Form 4
2025-08-15MLABOption exercise1,4042,128Form 4
2025-08-15MLABAward / grant2,7842,784Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.